Literature DB >> 32170699

Detection and Titration of Influenza A Virus Neuraminidase Inhibiting (NAI) Antibodies Using an Enzyme-Linked Lectin Assay (ELLA).

Bryan S Kaplan1, Amy L Vincent2.   

Abstract

The neuraminidase (NA) of influenza A viruses (IAV) is a structurally and antigenically important envelope glycoprotein. There are eleven known subtypes of NA of which two, N1 and N2, circulate in swine. The sialidase activity of NA is required for the release of nascent virus particles from infected cell membranes and inhibition of NA enzymatic activity can significantly reduce virus titers and duration of infection. Efforts to improve IAV vaccine technology in humans have focused on the generation of neuraminidase inhibiting (NAI) antibodies and should be considered in swine as well. The enzyme-linked lectin assay (ELLA) conducted in 96-well plates has enabled high-throughput analysis of serum samples for NAI antibody titers. Through the use of reverse genetics, custom antigen panels and antisera can be generated to encompass the antigenically diverse population of NA that circulate in swine. The ELLA is a robust method to assess NAI antibody titers and characterize the antigenic difference between NA antigens.

Entities:  

Keywords:  ELLA; Neuraminidase; Neuraminidase inhibition; Swine influenza A virus

Mesh:

Substances:

Year:  2020        PMID: 32170699     DOI: 10.1007/978-1-0716-0346-8_24

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

1.  Evolution and Antigenic Advancement of N2 Neuraminidase of Swine Influenza A Viruses Circulating in the United States following Two Separate Introductions from Human Seasonal Viruses.

Authors:  Bryan S Kaplan; Tavis K Anderson; Jennifer Chang; Jefferson Santos; Daniel Perez; Nicola Lewis; Amy L Vincent
Journal:  J Virol       Date:  2021-08-11       Impact factor: 5.103

2.  Inherent Serum Inhibition of Influenza Virus Neuraminidases.

Authors:  Amanda L Skarlupka; Ted M Ross
Journal:  Front Vet Sci       Date:  2021-08-02

3.  Validation of a Harmonized Enzyme-Linked-Lectin-Assay (ELLA-NI) Based Neuraminidase Inhibition Assay Standard Operating Procedure (SOP) for Quantification of N1 Influenza Antibodies and the Use of a Calibrator to Improve the Reproducibility of the ELLA-NI With Reverse Genetics Viral and Recombinant Neuraminidase Antigens: A FLUCOP Collaborative Study.

Authors:  Marie-Clotilde Bernard; Joanna Waldock; Sylvie Commandeur; Lea Strauß; Claudia Maria Trombetta; Serena Marchi; Fan Zhou; Serge van de Witte; Peter van Amsterdam; Sammy Ho; Katja Hoschler; Vladimir Lugovtsev; Jerry P Weir; Emanuele Montomoli; Rebecca J Cox; Othmar G Engelhardt; Damien Friel; Ralf Wagner; Thierry Ollinger; Sophie Germain; Hanna Sediri-Schön
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

4.  Vaccine-Associated Enhanced Respiratory Disease following Influenza Virus Infection in Ferrets Recapitulates the Model in Pigs.

Authors:  J Brian Kimble; Meghan Wymore Brand; Bryan S Kaplan; Phillip Gauger; Elizabeth M Coyle; Katarina Chilcote; Surender Khurana; Amy L Vincent
Journal:  J Virol       Date:  2022-01-05       Impact factor: 6.549

5.  Genetic and Antigenic Characterization of an Expanding H3 Influenza A Virus Clade in U.S. Swine Visualized by Nextstrain.

Authors:  Megan N Neveau; Michael A Zeller; Bryan S Kaplan; Carine K Souza; Phillip C Gauger; Amy L Vincent; Tavis K Anderson
Journal:  mSphere       Date:  2022-05-09       Impact factor: 5.029

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.